Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | p value | HR | 95%CI | p value | |
Total T (normal vs low) | 0.655 | 0.421–1.019 | 0.061 | |||
Free T (normal vs low) | 0.434 | 0.299–0.628 | < 0.001* | 0.564 | 0.377-0.843 | 0.005* |
Age (continuous) | 1.019 | 0.995–1.045 | 0.126 | |||
BMI (continuous) | 0.990 | 0.941–1.042 | 0.710 | |||
Diabetes (presence vs absence) | 0.888 | 0.549–1.436 | 0.628 | |||
Hypertension (presence vs absence) | 0.788 | 0.442–1.403 | 0.417 | |||
Coronary heart disease (presence vs absence) | 0.878 | 0.483–1.596 | 0.670 | |||
Smoke (presence vs absence) | 0.657 | 0.382–1.130 | 0.129 | |||
Alcohol (presence vs absence) | 0.982 | 0.646–1.493 | 0.931 | |||
PSA (≥10 ng/ml vs < 10 ng/ml) | 1.515 | 1.020–2.250 | 0.039* | 1.261 | 0.835-1.904 | 0.270 |
Proportion of free-PSA (≥ 0.16 vs < 0.16) | 0.794 | 0.527–1.196 | 0.296 | |||
Surgical approach (laparoscopic vs open) | 0.922 | 0.643–1.322 | 0.658 | |||
NVB preserve(presence vs absence) | 0.935 | 0.648–1.349 | 0.719 | |||
Pathological Tumor stage (T2a vs T3) | 0.270 | 0.116–0.626 | 0.002* | 0.333 | 0.128-0.804 | 0.014* |
Pathological Tumor stage (T2b vs T3) | 0.414 | 0.252–0.677 | < 0.001* | 0.457 | 0.268-0.780 | 0.004* |
Pathological Tumor stage (T2c vs T3) | 0.633 | 0.415–0.966 | 0.034* | 0.814 | 0.523-1.268 | 0.363 |
Final Gleason Score (6 vs 8 or higher) | 0.316 | 0.173–0.577 | < 0.001* | 0.532 | 0.278-1.019 | 0.057 |
Final Gleason Score (7 vs 8 or higher) | 0.518 | 0.353–0.761 | 0.001* | 0.647 | 0.431-0.971 | 0.036* |
Lymph node status (N- vs N+) | 0.328 | 0.167–0.644 | 0.001* | 0.523 | 0.259-1.054 | 0.070 |
Lymph node status (Nx vs N+) | 0.407 | 0.215–0.768 | 0.006* | 0.927 | 0.467-1.840 | 0.829 |
Seminal invasion (presence vs absence) | 2.483 | 1.255–4.914 | 0.009* | 1.048 | 0.497-2.211 | 0.902 |
PSM (presence vs absence) | 2.350 | 1.453–3.803 | 0.001* | 1.432 | 0.862-2.378 | 0.165 |